- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Veterinary Products
Price not available for DPHAF:US
Snapshot for Dechra Pharmaceuticals PLC (DPHAF)
| Open: | - | Day's Range: | - | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | - | 52wk Range: | - | 1-Yr Rtn: | - |
Key Statistics for DPHAF
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(06/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (GBP) (ttm) | - |
| Est. EPS (GBP) (06/2013) | 0.4030 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | - |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend (GBp) | 4.3400 |
| Last Dividend | 03/13/2013 |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 09/03/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for DPHAF
Company Profile & Key Executives for DPHAF
Dechra Pharmaceuticals PLC is an international pharmaceutical business focused on the veterinary market, with its key area of specialisation being the development and marketing of companion animal products. The Company Operates under four segments: European Pharmaceuticals, US Pharmaceuticals, Product Development and Services.
| Ian David PageChief Executive Officer | Anne-Francoise NesmesChief Financial Officer |
| Mike EldredPresident:US Operations | Edwin Thomas William Torr "Ed"Mng Dir:Dechra Veterinary |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
DPHAF News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page